Adicet Bio GAAP每股收益为-2.94美元

2026-03-13 04:52

Adicet Bio press release (ACET): FY GAAP EPS of -$2.94.
Net Loss: Net loss for the three months ended December 31, 2025 was $30.5 million, or a net loss of $2.94 per basic and diluted share, including non-cash stock-based compensation expense of $5.7 million, as compared to a net loss of $28.7 million, or a net loss of $5.06 per basic and diluted share, including non-cash stock-based compensation expense of $3.8 million during the same period in 2024.

More on Adicet Bio